As of June 30, 2026, Omaxe Limited carries a market capitalization of 14.79B, placing it among publicly traded companies globally. Its enterprise value stands at 14.79B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.79B |
| Enterprise Value | 14.79B |
As of June 30, 2026, Omaxe Limited has 182.90M shares outstanding.
| Shares Outstanding | 182.90M |
These figures are as of June 30, 2026.
| PS Ratio | 1.07 |
These figures are as of June 30, 2026. The EV/Sales ratio of 1.07 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 14.79B versus a market cap of 14.79B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.07 |
These figures are as of June 30, 2026.
| Interest Coverage | -2.41 |
These figures cover the twelve months ended June 30, 2026. The company generates approximately 13.33M in revenue per employee across its workforce of 1,033.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 13.33M |
| Employee Count | 1,033.00 |
Over the twelve months ended June 30, 2026, Omaxe Limited recorded an income tax benefit of -1.56B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -6.66B and -5.10B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -1.56B |
As of the close on October 22, 2026, Omaxe Limited's stock has gained approximately 30.72% over the past 52 weeks. The 50-day moving average sits at 111.44, while the 200-day moving average is 87.34.
| 52-Week Price Change | 30.72% |
| 50-Day Moving Average | 111.44 |
| 200-Day Moving Average | 87.34 |
Over the twelve months ended June 30, 2026, Omaxe Limited generated 13.77B in revenue and converted that into -5.10B in net income, yielding earnings per share of -27.98. EBITDA reached -5.19B, while operating income came in at -5.54B.
| Revenue | 13.77B |
| Gross Profit | -3.41B |
| Operating Income | -5.54B |
| Pretax Income | -6.66B |
| Net Income | -5.10B |
| EBITDA | -5.19B |
| EBIT | -5.54B |
| Earnings Per Share (EPS) | -27.98 |
Over the twelve months ended June 30, 2026, Omaxe Limited posted a gross margin of -24.74, reflecting its pricing power and cost economics. The operating margin of -40.23 and net profit margin of -37.04 provide insight into operational efficiency.
| Gross Margin | -24.74 |
| Operating Margin | -40.23 |
| Pretax Margin | -48.35 |
| Profit Margin | -37.04 |
| EBITDA Margin | -37.67 |
Omaxe Limited's most recent stock split took place on November 11, 2013 with a 39:49 split ratio.
| Last Split Date | 11/11/2013 |
| Split Ratio | 39:49 |
Already premium?